DSM-Firmenich Q3 2026 sales pass €2.3bn on volume-led growth

DSM-Firmenich posted Q3 2026 sales above €2.3bn and an 8% like-for-like rise in adjusted EBITDA to €482m, led by volume growth in perfumery and beauty during the quarter.